Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Safety and Effects of Sebetralstat for Children Aged 2-11 with Hereditary Angioedema Type I or II
ItalyStudy on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy
ItalyStudy on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
ItalyStudy on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis
ItalyStudy of Nous-209 Genetic Vaccine and Pembrolizumab for Patients with Advanced Microsatellite Instability-High Colorectal Cancer
ItalyStudy on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
ItalyStudy on the Long-Term Safety of Pimavanserin for Treating Irritability in Children and Adolescents with Autism Spectrum Disorder
ItalyStudy Comparing Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin versus High-Dose Chemotherapy with Paclitaxel and Drug Combination for Relapsed Germ Cell Tumors
ItalyStudy on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
ItalyStudy of Sitravatinib and Nivolumab vs. Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Chemotherapy and Checkpoint Inhibitor Therapy
ItalyStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
ItalyStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
